Global B Streptococcus (GBS) Infection Treatment Market Growth (Status and Outlook) 2023-2029

February 2023 | 87 pages | ID: G24124F9307FEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “B Streptococcus (GBS) Infection Treatment Industry Forecast” looks at past sales and reviews total world B Streptococcus (GBS) Infection Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected B Streptococcus (GBS) Infection Treatment sales for 2023 through 2029. With B Streptococcus (GBS) Infection Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world B Streptococcus (GBS) Infection Treatment industry.

This Insight Report provides a comprehensive analysis of the global B Streptococcus (GBS) Infection Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on B Streptococcus (GBS) Infection Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global B Streptococcus (GBS) Infection Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for B Streptococcus (GBS) Infection Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global B Streptococcus (GBS) Infection Treatment.

The global B Streptococcus (GBS) Infection Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for B Streptococcus (GBS) Infection Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for B Streptococcus (GBS) Infection Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for B Streptococcus (GBS) Infection Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key B Streptococcus (GBS) Infection Treatment players cover Pfizer Inc., Alopexx Pharmaceuticals, LLC, Wellstat Vaccines LLC, Minervax ApS, Novartis and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of B Streptococcus (GBS) Infection Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Prenatal-onset GBS Disease
  • Early-onset GBS Disease
  • Late-onset GBS Disease
Segmentation by application
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Pfizer Inc.
  • Alopexx Pharmaceuticals, LLC
  • Wellstat Vaccines LLC
  • Minervax ApS
  • Novartis
  • GlaxoSmithKline
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global B Streptococcus (GBS) Infection Treatment Market Size 2018-2029
  2.1.2 B Streptococcus (GBS) Infection Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 B Streptococcus (GBS) Infection Treatment Segment by Type
  2.2.1 Prenatal-onset GBS Disease
  2.2.2 Early-onset GBS Disease
  2.2.3 Late-onset GBS Disease
2.3 B Streptococcus (GBS) Infection Treatment Market Size by Type
  2.3.1 B Streptococcus (GBS) Infection Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
2.4 B Streptococcus (GBS) Infection Treatment Segment by Application
  2.4.1 Hospitals Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 B Streptococcus (GBS) Infection Treatment Market Size by Application
  2.5.1 B Streptococcus (GBS) Infection Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)

3 B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET SIZE BY PLAYER

3.1 B Streptococcus (GBS) Infection Treatment Market Size Market Share by Players
  3.1.1 Global B Streptococcus (GBS) Infection Treatment Revenue by Players (2018-2023)
  3.1.2 Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Players (2018-2023)
3.2 Global B Streptococcus (GBS) Infection Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 B STREPTOCOCCUS (GBS) INFECTION TREATMENT BY REGIONS

4.1 B Streptococcus (GBS) Infection Treatment Market Size by Regions (2018-2023)
4.2 Americas B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
4.3 APAC B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
4.4 Europe B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
5.2 Americas B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
5.3 Americas B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023)
6.2 APAC B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
6.3 APAC B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe B Streptococcus (GBS) Infection Treatment by Country (2018-2023)
7.2 Europe B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
7.3 Europe B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa B Streptococcus (GBS) Infection Treatment by Region (2018-2023)
8.2 Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET FORECAST

10.1 Global B Streptococcus (GBS) Infection Treatment Forecast by Regions (2024-2029)
  10.1.1 Global B Streptococcus (GBS) Infection Treatment Forecast by Regions (2024-2029)
  10.1.2 Americas B Streptococcus (GBS) Infection Treatment Forecast
  10.1.3 APAC B Streptococcus (GBS) Infection Treatment Forecast
  10.1.4 Europe B Streptococcus (GBS) Infection Treatment Forecast
  10.1.5 Middle East & Africa B Streptococcus (GBS) Infection Treatment Forecast
10.2 Americas B Streptococcus (GBS) Infection Treatment Forecast by Country (2024-2029)
  10.2.1 United States B Streptococcus (GBS) Infection Treatment Market Forecast
  10.2.2 Canada B Streptococcus (GBS) Infection Treatment Market Forecast
  10.2.3 Mexico B Streptococcus (GBS) Infection Treatment Market Forecast
  10.2.4 Brazil B Streptococcus (GBS) Infection Treatment Market Forecast
10.3 APAC B Streptococcus (GBS) Infection Treatment Forecast by Region (2024-2029)
  10.3.1 China B Streptococcus (GBS) Infection Treatment Market Forecast
  10.3.2 Japan B Streptococcus (GBS) Infection Treatment Market Forecast
  10.3.3 Korea B Streptococcus (GBS) Infection Treatment Market Forecast
  10.3.4 Southeast Asia B Streptococcus (GBS) Infection Treatment Market Forecast
  10.3.5 India B Streptococcus (GBS) Infection Treatment Market Forecast
  10.3.6 Australia B Streptococcus (GBS) Infection Treatment Market Forecast
10.4 Europe B Streptococcus (GBS) Infection Treatment Forecast by Country (2024-2029)
  10.4.1 Germany B Streptococcus (GBS) Infection Treatment Market Forecast
  10.4.2 France B Streptococcus (GBS) Infection Treatment Market Forecast
  10.4.3 UK B Streptococcus (GBS) Infection Treatment Market Forecast
  10.4.4 Italy B Streptococcus (GBS) Infection Treatment Market Forecast
  10.4.5 Russia B Streptococcus (GBS) Infection Treatment Market Forecast
10.5 Middle East & Africa B Streptococcus (GBS) Infection Treatment Forecast by Region (2024-2029)
  10.5.1 Egypt B Streptococcus (GBS) Infection Treatment Market Forecast
  10.5.2 South Africa B Streptococcus (GBS) Infection Treatment Market Forecast
  10.5.3 Israel B Streptococcus (GBS) Infection Treatment Market Forecast
  10.5.4 Turkey B Streptococcus (GBS) Infection Treatment Market Forecast
  10.5.5 GCC Countries B Streptococcus (GBS) Infection Treatment Market Forecast
10.6 Global B Streptococcus (GBS) Infection Treatment Forecast by Type (2024-2029)
10.7 Global B Streptococcus (GBS) Infection Treatment Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer Inc.
  11.1.1 Pfizer Inc. Company Information
  11.1.2 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Product Offered
  11.1.3 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Pfizer Inc. Main Business Overview
  11.1.5 Pfizer Inc. Latest Developments
11.2 Alopexx Pharmaceuticals, LLC
  11.2.1 Alopexx Pharmaceuticals, LLC Company Information
  11.2.2 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Product Offered
  11.2.3 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Alopexx Pharmaceuticals, LLC Main Business Overview
  11.2.5 Alopexx Pharmaceuticals, LLC Latest Developments
11.3 Wellstat Vaccines LLC
  11.3.1 Wellstat Vaccines LLC Company Information
  11.3.2 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Product Offered
  11.3.3 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Wellstat Vaccines LLC Main Business Overview
  11.3.5 Wellstat Vaccines LLC Latest Developments
11.4 Minervax ApS
  11.4.1 Minervax ApS Company Information
  11.4.2 Minervax ApS B Streptococcus (GBS) Infection Treatment Product Offered
  11.4.3 Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Minervax ApS Main Business Overview
  11.4.5 Minervax ApS Latest Developments
11.5 Novartis
  11.5.1 Novartis Company Information
  11.5.2 Novartis B Streptococcus (GBS) Infection Treatment Product Offered
  11.5.3 Novartis B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Novartis Main Business Overview
  11.5.5 Novartis Latest Developments
11.6 GlaxoSmithKline
  11.6.1 GlaxoSmithKline Company Information
  11.6.2 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Product Offered
  11.6.3 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 GlaxoSmithKline Main Business Overview
  11.6.5 GlaxoSmithKline Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. B Streptococcus (GBS) Infection Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Prenatal-onset GBS Disease
Table 3. Major Players of Early-onset GBS Disease
Table 4. Major Players of Late-onset GBS Disease
Table 5. B Streptococcus (GBS) Infection Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 8. B Streptococcus (GBS) Infection Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global B Streptococcus (GBS) Infection Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Player (2018-2023)
Table 13. B Streptococcus (GBS) Infection Treatment Key Players Head office and Products Offered
Table 14. B Streptococcus (GBS) Infection Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global B Streptococcus (GBS) Infection Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global B Streptococcus (GBS) Infection Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of B Streptococcus (GBS) Infection Treatment
Table 46. Key Market Challenges & Risks of B Streptococcus (GBS) Infection Treatment
Table 47. Key Industry Trends of B Streptococcus (GBS) Infection Treatment
Table 48. Global B Streptococcus (GBS) Infection Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global B Streptococcus (GBS) Infection Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global B Streptococcus (GBS) Infection Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Inc. Details, Company Type, B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 53. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Product Offered
Table 54. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Inc. Main Business
Table 56. Pfizer Inc. Latest Developments
Table 57. Alopexx Pharmaceuticals, LLC Details, Company Type, B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 58. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Product Offered
Table 59. Alopexx Pharmaceuticals, LLC Main Business
Table 60. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Alopexx Pharmaceuticals, LLC Latest Developments
Table 62. Wellstat Vaccines LLC Details, Company Type, B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 63. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Product Offered
Table 64. Wellstat Vaccines LLC Main Business
Table 65. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Wellstat Vaccines LLC Latest Developments
Table 67. Minervax ApS Details, Company Type, B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 68. Minervax ApS B Streptococcus (GBS) Infection Treatment Product Offered
Table 69. Minervax ApS Main Business
Table 70. Minervax ApS B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Minervax ApS Latest Developments
Table 72. Novartis Details, Company Type, B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 73. Novartis B Streptococcus (GBS) Infection Treatment Product Offered
Table 74. Novartis Main Business
Table 75. Novartis B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Novartis Latest Developments
Table 77. GlaxoSmithKline Details, Company Type, B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 78. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Product Offered
Table 79. GlaxoSmithKline Main Business
Table 80. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. GlaxoSmithKline Latest Developments

LIST OF FIGURES

Figure 1. B Streptococcus (GBS) Infection Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global B Streptococcus (GBS) Infection Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. B Streptococcus (GBS) Infection Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. B Streptococcus (GBS) Infection Treatment Sales Market Share by Country/Region (2022)
Figure 8. B Streptococcus (GBS) Infection Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type in 2022
Figure 10. B Streptococcus (GBS) Infection Treatment in Hospitals Pharmacies
Figure 11. Global B Streptococcus (GBS) Infection Treatment Market: Hospitals Pharmacies (2018-2023) & ($ Millions)
Figure 12. B Streptococcus (GBS) Infection Treatment in Retail Pharmacies
Figure 13. Global B Streptococcus (GBS) Infection Treatment Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. B Streptococcus (GBS) Infection Treatment in Online Pharmacies
Figure 15. Global B Streptococcus (GBS) Infection Treatment Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2022
Figure 17. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Player in 2022
Figure 18. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas B Streptococcus (GBS) Infection Treatment Value Market Share by Country in 2022
Figure 24. United States B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region in 2022
Figure 29. APAC B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type in 2022
Figure 30. APAC B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2022
Figure 31. China B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country in 2022
Figure 38. Europe B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Application (2024-2029)


More Publications